Lexology November 9, 2022
In response to the COVID-19 pandemic, the White House Office of Science & Technology Policy and the Office of the National Coordinator for Health Information Technology take a major step towards testing interoperability capabilities in clinical trials. The regulatory and technological framework for the interoperability of Electronic Health Records platforms could be applied to the clinical trials context. Shift towards the use of interoperable technologies could improve the collection and exchange of clinical trials data between institutions in emergent and non-emergent settings.
In response to the COVID-19 pandemic, the Biden administration recently announced its National Biodefense Strategy aimed at national preparedness for biological threats. The National Biodefense Strategy sets several targets for improved capabilities in order to respond to biologic...